Liangzhi Xie

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Medicine · Health Sciences

20h-index1.7kcitations92works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(35), Viral Infectious Diseases and Gene Expression in Insects(17), COVID-19 Clinical Research Studies(14), Immunotherapy and Immune Responses(8), Vaccine Coverage and Hesitancy(8)

Publications92 total

Knee Joint Infection Caused by Scedosporium aurantiacum
Mycopathologia·2025
Comparative analysis of neutralization assays performed using live SARS-CoV-2 virus and pseudovirus to assess immunogenicity of a bivalent SARS-CoV-2 protein vaccine in humans
Frontiers in Immunology·2025Open Access
Baseline Anti-SARS-CoV-2 IgG and Protection from Symptomatic Infection: Post Hoc Analysis of the SCTV01E Phase 3 Randomized Trial
Vaccines·2025Open Access
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Signal Transduction and Targeted Therapy·2025· 5 citedOpen Access
Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history
Microbiology Spectrum·2025· 1 citedOpen Access
Reverse–normal immunopurification: An effective approach for purifying recombinant erythropoietin from its analogues in doping analysis
Journal of sport and health science/Journal of Sport and Health Science·2025· 1 citedOpen Access
Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial
Contemporary Clinical Trials Communications·2025· 1 citedOpen Access
Comparative Statistical Analysis between Neutralization Assays in Vaccine Immunogenicity Assessments
Preprints.org·2025Open Access
Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial
Translational Lung Cancer Research·2025· 3 citedOpen Access
Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients
Vaccines·2025Open Access
Postoperative radiotherapy improves long-term survival in HER2-positive metastatic breast cancer: real-world evidence from the latest SEER database
Breast Cancer Research and Treatment·2025
Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody
Pharmaceuticals·2025· 3 citedOpen Access
Developmental and reproductive toxicity (DART) study of a novel SARS-CoV-2 tetravalent recombinant protein vaccine (SCTV01E) in rats
Reproductive Toxicology·2025Open Access
P133: Association between diabetes and the risk of breast cancer lymph nodes metastasis
The Breast·2025Open Access
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
Cancer Letters·2025· 2 cited
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants
Expert Review of Vaccines·2025· 3 citedOpen Access
Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Vaccines·2025Open Access
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial
Research and Practice in Thrombosis and Haemostasis·2024· 1 citedOpen Access
Immunogenicity Assessment of a 14-Valent Human Papillomavirus Vaccine Candidate in Mice
Vaccines·2024· 3 citedOpen Access
Tip Optofluidic Immunoassay: Evaluating COVID-19 Antibody Protection with 1μL Fingertip Blood
2024Open Access
page 1 of 5Next →

Frequent Co-authors

Wenlin Gai(13), Daniel I. C. Wang(7), Chunyun Sun(7), Chulin Yu(5), Yuanxin Chen(5), Juan Ma(4), Desheng Kong(4), Yanjing Zhang(4), Chunxia Luo(4), Yuankai Shi(4), Suad Hannawi(4), Linda Saf Eldin(4), Alaa Abuquta(4), Ahmad Alamadi(4), Sally Mahmoud(4), Jian Li(4), Weichang Zhou(3), Xuefeng Li(3), Rui Wang(3), Dandan Zhao(3)